PegasusBiotech

Pegasus Biotech Inc. is a Canada-based contract research organization (CRO) headquartered in Prince Edward Island, serving the global vaccine and biopharmaceutical industry. It works with clients in human and animal health to advance biologic products from proof of concept toward production and commercialization, with attention to regulatory requirements and commercial viability.

The company offers analytical development, including the development and validation of immunoassays, molecular assays, chromatography methods, and cell-based bioassays. Its services also include animal health vaccine and biopharmaceutical development, DNA vaccine development from early research through technology transfer, and process development to optimize media formulations and growth conditions.

Projects typically move through discovery, development, and deployment. Pegasus helps define deliverables and project plans, develops upstream, downstream, and analytical processes in its CL1 and CL2 laboratories, and can support method validation, technology transfer, and project reporting. The company emphasizes tailored project structures, deliverable-based pricing, and quality management suited to client needs.